Application of targeted next generation sequencing technology in the diagnosis of Mycobacterium Tuberculosis and first line drugs resistance directly from cell-free …

X Wu, R Liang, Y Xiao, H Liu, Y Zhang… - Journal of …, 2023 - journalofinfection.com
Tuberculosis (TB) is a communicable disease that continues a significant threat to global
public health threats, and is one of the leading causes of death worldwide. The World Health …

Host blood protein biomarkers to screen for Tuberculosis disease: a systematic review and meta-analysis

M Gaeddert, K Glaser, BH Chendi… - Journal of Clinical …, 2024 - journals.asm.org
Non-sputum tests are needed to improve tuberculosis (TB) diagnosis and close the
diagnostic gap. The World Health Organization's target product profile (TPP) for point-of-care …

Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia …

M Ruperez, K Shanaube, L Mureithi… - The Lancet Global …, 2023 - thelancet.com
Background WHO recommends community-wide, systematic tuberculosis screening in high-
prevalence settings. C-reactive protein has been proposed as a tuberculosis screening tool …

Clinical identification and microbiota analysis of Chlamydia psittaci- and Chlamydia abortus- pneumonia by metagenomic next-generation sequencing

G Xie, Q Hu, X Cao, W Wu, P Dai, W Guo… - Frontiers in Cellular …, 2023 - frontiersin.org
Introduction Recently, the incidence of chlamydial pneumonia caused by rare pathogens
such as C. psittaci or C. abortus has shown a significant upward trend. The non-specific …

Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross …

BWP Reeve, G Ndlangalavu, H Mishra… - The Lancet Global …, 2024 - thelancet.com
Background Tuberculosis, a major cause of death in people living with HIV, remains
challenging to diagnose. Diagnostic accuracy data are scarce for promising triage and …

Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among …

A Dhana, RK Gupta, Y Hamada… - European …, 2023 - Eur Respiratory Soc
Background: The World Health Organization (WHO) recommends that outpatient people
living with HIV (PLHIV) undergo tuberculosis screening with the WHO four-symptom screen …

[HTML][HTML] Blood RNA biomarkers for tuberculosis screening in people living with HIV before antiretroviral therapy initiation: a diagnostic accuracy study

T Mann, RK Gupta, BWP Reeve… - The Lancet Global …, 2024 - thelancet.com
Background Undiagnosed tuberculosis remains a major threat for people living with HIV.
Multiple blood transcriptomic biomarkers have shown promise for tuberculosis diagnosis …

Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa

S Bosman, I Ayakaka, J Muhairwe… - Clinical Infectious …, 2024 - academic.oup.com
Background To improve tuberculosis case-finding, rapid, non-sputum triage tests need to be
developed according to the World Health Organization target product profile (TPP)(> 90 …

[HTML][HTML] Blood RNA signatures outperform CRP triage of tuberculosis lymphadenitis and pericarditis

T Mann, S Minnies, RK Gupta, BWP Reeve… - medRxiv, 2024 - pmc.ncbi.nlm.nih.gov
Background Limited data are available on the diagnostic accuracy of blood RNA biomarker
signatures for extrapulmonary TB (EPTB). We addressed this question among people …

Integrating systemic immune-inflammation index, fibrinogen, and T-SPOT. TB for precision distinction of active pulmonary tuberculosis in the era of mycobacterial …

Z Yu, Z Shang, Q Huang, F Wen, S Patil - Frontiers in Microbiology, 2024 - frontiersin.org
Background The clinical challenge of differentiating suspected tuberculosis with positive T-
SPOT. TB results persist. This study aims to investigate the utility of the Systemic Immune …